Genelink Profit Margin

Genelink (GNLKQ) currently reports a profit margin of -128.81% as of September 2013. That compares with -136.21% in the prior-year period — up 5.4% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Genelink's profit margin history and peer comparisons.

Genelink's profit margin increased from -136.21% to -128.81% — a 5.4% year-over-year increase (period ending September 2013). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genelink's profit margin of -128.81% is lower than the Healthcare sector average of 13.89%. That is roughly 1027.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Genelink's current -128.81% should be judged against Healthcare norms (sector average: 13.89%) and against GNLKQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -128.81%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Genelink, and consider following GNLKQ for alerts when major investors trade the stock.